日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

COVID-19 in thrombosis research: An editorial perspective

COVID-19 与血栓形成研究:社论观点

Barco, S; Bates, S M; Versteeg, H H; Klok, F A

IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model

IL4-10 融合蛋白在大鼠骨关节炎模型中表现出 DMOAD 活性

E M van Helvoort, H M de Visser, F P J G Lafeber, K Coeleveld, S Versteeg, H H Weinans, J Popov-Celeketic, N Eijkelkamp, S C Mastbergen

mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors.

mTOR激酶抑制剂可降低组织因子表达和胰腺神经内分泌肿瘤的生长。

Lewis C S, Elnakat Thomas H, Orr-Asman M A, Green L C, Boody R E, Matiash K, Karve A, Hisada Y M, Davis H W, Qi X, Mercer C A, Lucas F V, Aronow B J, Mackman N, Versteeg H H, Bogdanov V Y

Interplay between alternatively spliced Tissue Factor and full length Tissue Factor in modulating coagulant activity of endothelial cells

组织因子选择性剪接与全长组织因子在调节内皮细胞凝血活性中的相互作用

Ünlü, B; Bogdanov, V Y; Versteeg, H H

Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression

选择性剪接的组织因子与雌激素受体通路协同作用,促进乳腺癌进展。

Kocatürk, B; Tieken, C; Vreeken, D; Ünlü, B; Engels, C C; de Kruijf, E M; Kuppen, P J; Reitsma, P H; Bogdanov, V Y; Versteeg, H H

Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling.

组织因子剪接变体通过整合素介导的信号传导触发细胞粘附分子的表达,从而促进单核细胞与内皮细胞的相互作用

Srinivasan R, Ozhegov E, van den Berg Y W, Aronow B J, Franco R S, Palascak M B, Fallon J T, Ruf W, Versteeg H H, Bogdanov V Y

Alternatively spliced tissue factor induces angiogenesis through integrin ligation

选择性剪接的组织因子通过整合素配体结合诱导血管生成

van den Berg, Y W; van den Hengel, L G; Myers, H R; Ayachi, O; Jordanova, E; Ruf, W; Spek, C A; Reitsma, P H; Bogdanov, V Y; Versteeg, H H